Ketamine, which has been called “the most important discovery in half a century,” just got a step closer to becoming the first new depression drug in 35 years. Johnson & Johnson, one of the pharmaceutical companies pursuing the drug’s fast-acting antidepressant qualities, presented some promising new research on Saturday that could raise the drug’s profile as a potential treatment for the condition. Read more here.
A Depression Drug That Researchers Have Called ‘The Most Important Discovery in Half a Century’ Just Got a Big Lift
Depression Linked to 44 Genes in Major New Study
Scientists have identified dozens of genes that could increase the risk of developing depression in a major new study which could pave the way for more effective treatments. Read more here.
